Trial Profile
A Double-Blind Placebo Controlled Trial of Infliximab in Patients with Corticosteroid-Dependent Polymyalgia Rheumatica.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2011
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Polymyalgia rheumatica
- Focus Therapeutic Use
- 03 Mar 2011 New trial record